Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,034 | 429 | 99.2% |
| Education | $66.80 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,578 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,045 | 59 | $0 (2023) |
| Novo Nordisk Inc | $958.76 | 50 | $0 (2024) |
| ABBVIE INC. | $911.75 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $698.86 | 22 | $0 (2020) |
| Lilly USA, LLC | $441.31 | 27 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $377.46 | 31 | $0 (2022) |
| PFIZER INC. | $349.46 | 31 | $0 (2024) |
| Allergan, Inc. | $283.54 | 15 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $201.12 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $981.01 | 46 | AstraZeneca Pharmaceuticals LP ($521.39) |
| 2023 | $604.63 | 45 | AbbVie Inc. ($256.23) |
| 2022 | $1,091 | 62 | Biohaven Pharmaceutical Holding Company Ltd. ($377.46) |
| 2021 | $1,439 | 72 | AstraZeneca Pharmaceuticals LP ($517.92) |
| 2020 | $732.74 | 44 | GlaxoSmithKline, LLC. ($253.15) |
| 2019 | $903.16 | 43 | Janssen Pharmaceuticals, Inc ($263.42) |
| 2018 | $1,089 | 54 | Novo Nordisk Inc ($317.85) |
| 2017 | $1,260 | 68 | Janssen Pharmaceuticals, Inc ($411.59) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: PAIN | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: PAIN | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: PAIN | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: PAIN | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.69 | General |
| 07/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: PAIN | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: PAIN | ||||||
| 06/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 403 | 590 | $86,730 | $43,684 |
| 2022 | 11 | 386 | 559 | $75,305 | $39,406 |
| 2021 | 14 | 474 | 613 | $68,507 | $38,243 |
| 2020 | 10 | 353 | 501 | $59,615 | $30,582 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 253 | $44,370 | $21,507 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $9,744 | $5,979 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 89 | $11,125 | $5,317 | 47.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $11,970 | $5,092 | 42.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 34 | $2,278 | $2,232 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 40 | $1,763 | $1,174 | 66.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $1,300 | $834.24 | 64.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $924.00 | $616.56 | 66.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 17 | $1,596 | $551.40 | 34.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 22 | $880.00 | $199.92 | 22.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $420.00 | $104.77 | 24.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 24 | $360.00 | $73.83 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 252 | $41,564 | $20,752 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 68 | 68 | $13,804 | $8,719 | 63.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 19 | 19 | $5,567 | $2,516 | 45.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $2,144 | $2,035 | 94.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 38 | $5,000 | $1,884 | 37.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 22 | $2,200 | $1,224 | 55.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,540 | $951.72 | 61.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $836.00 | $537.56 | 64.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 11 | 11 | $880.00 | $374.30 | 42.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 22 | 33 | $1,320 | $315.92 | 23.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 20 | 30 | $450.00 | $96.94 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 184 | $19,504 | $11,532 | 59.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 65 | 65 | $13,195 | $8,352 | 63.3% |
About Peter Striegel
Peter Striegel is a Family Medicine healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588753123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Striegel has received a total of $8,101 in payments from pharmaceutical and medical device companies, with $981.01 received in 2024. These payments were reported across 434 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,034).
As a Medicare-enrolled provider, Striegel has provided services to 1,616 Medicare beneficiaries, totaling 2,263 services with total Medicare billing of $151,914. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cuyahoga Falls, OH
- Active Since 10/12/2006
- Last Updated 12/22/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1588753123
Products in Payments
- FARXIGA (Drug) $707.51
- XARELTO (Drug) $571.57
- NURTEC ODT (Drug) $546.88
- VRAYLAR (Drug) $525.50
- BREZTRI (Drug) $517.26
- Ozempic (Drug) $415.72
- TRELEGY ELLIPTA (Drug) $371.58
- UBRELVY (Drug) $287.42
- AIRSUPRA (Drug) $281.75
- Victoza (Drug) $238.48
- ANORO ELLIPTA (Drug) $229.90
- SHINGRIX (Biological) $170.22
- JARDIANCE (Drug) $161.24
- SOLIQUA (Drug) $146.00
- TRULICITY (Drug) $142.83
- Aimovig (Biological) $135.53
- Tresiba (Drug) $129.78
- MOUNJARO (Drug) $126.73
- INVOKANA (Drug) $121.27
- QULIPTA (Drug) $109.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cuyahoga Falls
Dr. Tricia Bedrick, D.o, D.O
Family Medicine — Payments: $223,294
Muhamad Musa, M.d, M.D
Family Medicine — Payments: $19,605
Dr. Scott Higley, D.o, D.O
Family Medicine — Payments: $16,424
William Schukay, Do, DO
Family Medicine — Payments: $16,108
James Johnston, D.o, D.O
Family Medicine — Payments: $15,241
Victoria Digennaro, D.o, D.O
Family Medicine — Payments: $13,874